Exploring the neurophysiological basis of chest wall allodynia induced by experimental oesophageal acidification - Evidence of central sensitization

Neurogastroenterology and Motility

Volumn 19, Issue 4, 2007, Pages 270-278

  Willert, R P ^a   Delaney, C ^a   Kelly, K ^a   Sharma, A ^a   Aziz, Q ^a   Hobson, A R ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Central sensitization: chest wall evoked potentials; N methyl D aspartate receptor; Visceral hypersensitivity

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SODIUM CHLORIDE;

ADULT; AFFERENT NERVE GROUP 1; ALLODYNIA; ARTICLE; BETA NERVE FIBER; CONTROLLED STUDY; ELECTROSTIMULATION; ESOPHAGUS PH; EVOKED RESPONSE; FEMALE; FOOT PAIN; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPHYSIOLOGY; NORMAL HUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; SOMATIC CELL; THORAX PAIN; THORAX WALL; VISCERA;

ADULT; ANALGESICS; ELECTRIC STIMULATION; ESOPHAGUS; EVOKED POTENTIALS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERALGESIA; KETAMINE; MALE; MIDDLE AGED; NUTRITIONAL STATUS; THORACIC DISEASES; THORAX;

EID: 33947527858     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2006.00890.x     Document Type: Article

References (38)

1. Cook AJ, Woolf CJ, Wall PD, McMahon SB. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 1987; 325: 151-3.
2. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001; 413: 203-10.
3. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306: 686-8.
4. Woolf CJ, King AE. Dynamic alterations in the cutaneous mechanoreceptive fields of dorsal horn neurons in the rat spinal cord. J Neurosci 1990; 10: 2717-26.
5. Woolf CJ. An overview of the mechanisms of hyperalgesia. Pulm Pharmacol 1995; 8: 161-7.
6. Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293-9.
7. Ilkjaer S, Petersen KL, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth 1996; 76: 829-34.
8. Andersen OKFS, Nicolaisen L, Bjerring P, Jensen TS, Arendt-Nielsen L. The effect of ketamine on stimulation of primary and secondary hyperalgesia areas induced by capsaicin - a double blind placebo controlled, human experimental study. Pain 1996; 66: 829-34.
9. Gebhart GF, Ness TJ. Central mechanisms of visceral pain. Can J Physiol Pharmacol 1991; 69: 627-34.
10. Moshiree B, Zhou Q, Price DD, Verne GN. Central sensitisation in visceral pain disorders. Gut 2006; 55: 905-8.
11. Hobson AR, Aziz Q. Brain processing of esophageal sensation in health and disease. Gastroenterol Clin North Am 2004; 33: 69-91.
12. Frieling T, Enck P, Wienbeck M. Cerebral responses evoked by electrical stimulation of the esophagus in normal subjects. Gastroenterology 1989; 97: 475-8.
13. Hobson AR, Aziz Q, Furlong PL, Barlow JD, Bancewicz J, Thompson DG. Identification of the optimal parameters for recording cortical evoked potentials to human oesophageal electrical stimulation. Neurogastroenterol Motil 1998; 10: 421-30.
14. Hobson AR, Sarkar S, Furlong PL, Thompson DG, Aziz Q. A cortical evoked potential study of afferents mediating human esophageal sensation. Am J Physiol Gastrointest Liver Physiol 2000; 279: G139-47.
15. Aziz Q, Thompson DG. Brain-gut axis in health and disease. Gastroenterology 1998; 114: 559-78.
16. Hobson AR, Furlong PL, Sarkar S et al. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology 2006; 130: 80-8.
17. Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 2000; 356: 1154-9.
18. Willert RP, Woolf CJ, Hobson AR, Delaney C, Thompson DG, Aziz Q. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methly-D-aspartate receptor. Gastroenterology 2004; 126: 683-92.
19. Sarkar S, Hobson AR, Furlong PL, Woolf CJ, Thompson DG, Aziz Q. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1196-202.
20. Willert RP, Delaney C, Hobson AR, Thompson DG, Woolf CJ, Aziz Q. Constitutive cyclo-oxygenase-2 does not contribute to the development of human visceral pain hypersensitivity. Eur J Pain 2006; 10: 487-94.
21. Garrison DW, Chandler MJ, Foreman RD. Viscerosomatic convergence onto feline spinal neurons from esophagus, heart and stomach fields: effects of inflammation. Pain 1992; 49: 373-82.
22. Aziz Q, Furlong PL, Barlow J et al. Topographic mapping of cortical potentials evoked by distension of the human proximal and distal oesophagus. Electroencephalogr Clin Neurophysiol 1995; 96: 219-28.
23. Clements JA, Nimmo WS. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981; 53: 27-30.
24. Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci 1982; 71: 539-42.
25. Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP, Domino SE. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 1982; 61: 87-92.
26. Strauss E, Spellacy F, Hunter M, Berry T. Assessing believable deficits of measures of attention and information processing capacity. Arch Clin Neuropsychol 1994; 9: 483-90.
27. Sarkar S, Hobson AR, Hughes A et al. The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology 2003; 124: 18-25.
28. Desmedt JE. Somatosensory CEP in man. In: Cobb WA, ed. Handbook of Electroencephalography and Neurophysiology. Amsterdam: Elsevier, 1971: 55-82.
29. Svensson P, Arendt-Nielsen L, Kaaber S, Bjerring P. Vertex potentials evoked by nociceptive laser stimulation of oral mucosa: relationship to stimulus intensity. Anesth Pain Control Dent 1993; 2: 27-33.
30. Arendt-Nielsen L. Characteristics, detection and modulation of laser-evoked vertex potentials. Acta Anaesthesiol Scand Suppl 1994; 101: 7-44.
31. Giesler GJ Jr, Liebeskind JC. Inhibition of visceral pain by electrical stimulation of the periaqueductal gray matter. Pain 1976; 2: 43-8.
32. Cervero F, Lumb B, Tattersall J. Supraspinal loops that mediate visceral inputs to thoracic spinal cord neurones in the cat. Neurosci Lett 1985; 56: 189-94.
33. Ness TJ, Gebhart GF. Quantitative comparison of inhibition of visceral and cutaneous spinal nociceptive transmission from the midbrain and medulla in the rat. J Neurophysiol 1987; 58: 850-65.
34. Zhuo MGG. Facilitation and attention of a visceral nociceptive reflex from the rostroventral medulla in the rat. Gastroenterology 2002; 122: 1007-19.
35. Coutinho SV, Urban MO, Gebhart GF. The role of CNS NMDA receptors and nitric oxide in visceral hyperalgesia. Eur J Pharmacol 2001; 429: 319-25.
36. Bradshaw K. Somatosensory electrophysiology. Clin Phys Physiol Meas 1988; 3: 195-231.
37. Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66: 355-474.
38. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2001; 93: 7-14.